A Phase Ⅰ Trial to Evaluate the Safety and Immunogenicity of SARS-CoV-2 Vaccine LYB001
Clinical trial NCT05125926 · UNKNOWN
Trial details
- NCT number
- NCT05125926
- Sponsor
- Yantai Patronus Biotech Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-01
- Primary completion
- 2023-02-01
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.